Tianjin Lisheng Pharmaceutical Co Ltd Long-term Investment Intensity
Tianjin Lisheng Pharmaceutical Co Ltd long-term investment intensity. Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Long-term Investment Intensity of 33.7% as of September 2019. Long-term investments of CN¥1.90 Billion represent 33.7% of total assets of CN¥5.62 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Tianjin Lisheng Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Tianjin Lisheng Pharmaceutical Co Ltd (2015–2018)
Long-term investment intensity of Tianjin Lisheng Pharmaceutical Co Ltd from 2015 to 2018. This chart shows how Tianjin Lisheng Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 33.7%, reflecting long-term investments of CN¥1.90 Billion against total assets of CN¥5.62 Billion CNY.
Tianjin Lisheng Pharmaceutical Co Ltd Long-term Investment Intensity by Year (2015–2018)
Tianjin Lisheng Pharmaceutical Co Ltd long-term investment intensity by year from 2015 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Tianjin Lisheng Pharmaceutical Co Ltd from 2015 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Tianjin Lisheng Pharmaceutical Co Ltd balance sheet assets.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 7.5% | CN¥294.11 Million | CN¥3.92 Billion | ▼ -1.3 pp |
| 2016 | 8.8% | CN¥305.91 Million | CN¥3.49 Billion | ▲ +2.0 pp |
| 2015 | 6.8% | CN¥232.18 Million | CN¥3.41 Billion | — |